Ipilimumab/nivolumabHypophysitis, hypothyroidism and adrenal insufficiency: case report

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2021年 / 1852卷 / 1期

关键词：

D O I：

10.1007/s40278-021-94700-z

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：247 / 247

相关论文

共 50 条

[41] Ipilimumab/nivolumabHypothyroidism, adrenal insufficiency and type I diabetes mellitus: case report
[J]. Reactions Weekly, 2020, 1795 (1) : 163 - 163
[42] Ipilimumab/nivolumabHypophysitis
[J]. Reactions Weekly, 2024, 2011 (1) : 226 - 226
[43] Ipilimumab/nivolumabAdrenal insufficiency: case report
[J]. Reactions Weekly, 2023, 1973 (1) : 148 - 148
[44] Ipilimumab/nivolumabAdrenal insufficiency: case report
[J]. Reactions Weekly, 2020, 1828 (1) : 285 - 285
[45] Ipilimumab/pembrolizumabAdrenal insufficiency: case report
[J]. Reactions Weekly, 2016, 1606 (1) : 94 - 94
[46] Ipilimumab/nivolumabHypophysitis and cerebral amyloid angiopathy-related inflammation: case report
[J]. Reactions Weekly, 2021, 1872 (1) : 267 - 267
[47] NivolumabHypophysitis: case report
[J]. Reactions Weekly, 2017, 1641 (1) : 198 - 198
[48] Ipilimumab/nivolumabImmune thrombocytopenia and hypothyroidism: case report
[J]. Reactions Weekly, 2022, 1926 (1) : 278 - 278
[49] NivolumabHypophysitis: case report
[J]. Reactions Weekly, 2020, 1787 (1) : 394 - 394
[50] Ipilimumab/nivolumabHypophysitis and adrenalitis
[J]. Reactions Weekly, 2024, 2006 (1) : 343 - 343

← 1 2 3 4 5 →